MLH1 PROMOTER HYPERMETHYLATION IN BULGARIAN PATIENTS WITH COLORECTAL CANCER
Kadiyska T1,*, Tzancheva M1, Nedin D2, Alexandrova A2, Marinov M2, Kaneva R1, Damyanov D2, Mitev V3, Kremensky I1
*Corresponding Author: Dr. Tanya Kadiyska, Laboratory of Molecular Pathology, University Hospital of Obstetrics and Gynaecology “Maichin Dom”, 2 Zdrave str., Sofia 1431, Bulgaria; Tel: +359-2-9520124; Fax: +359-2-9520490; E-mail: alextanya@excite.com
page: 3

REFERENCES

1. Thomas, D. C., Umar, A. & Kunkel, T. A. Microsatellite instability and mismatch repair defects in cancer. Mutat. Res. 1996; 350, 201–205.

2. Modrich, P. & Lahue, R. Mismatch repair in replication fidelity, genetic recombination, and cancer biology. Annu. Rev. Biochem. 1996; 65, 101–33, 101–133.

3. Marra, G. & Boland, C. R. Hereditary nonpolyposis colorectal cancer: the syndrome, the genes, and historical perspectives. J. Natl. Cancer Inst. 1995; 87, 1114–1125.

4. Kolodner, R. Biochemistry and genetics of eukaryotic mismatch repair. Genes Dev. 1996; 10, 1433–1442.

5. Kinzler KW, Vogelstein B. Lessons from hereditary colon cancer. Cell 1996; 87: 159-70.

6. Eshleman, J. & Markowitz, S. Microsatellite instability in inherited and sporadic neoplasms. Curr. Opin. Oncol. 1995; 7, 83–89.

7. Perucho, M. Cancer of the microsatellite mutator phenotype Biol. Chem. 1996; 377, 675–684.

8. Lynch HT, Smyrk TC, Watson P, et al. Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastroenterology 1993; 104: 1535-49.

9. Lynch HT, and de la Chapelle A. Genetic susceptibility to non-polyposis colorectal cancer . J. Med. Genet. 1999, 36:801-818.

10. Lothe RA, Peltomaki P, Meling GI, et al. Genomic instability in colorectal cancer: relationship to clinicopathological variables and family history. Cancer Res 1993; 53: 5849-52.

11. Kim H, Jen J, Vogelstein B, Hamilton SR. Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences. Am J Pathol 1994; 145:148-56.

12. Peltomaki P, de la Chapelle A. Mutations predisposing to hereditary nonpolyposis colorectal cancer. In: Vande Woude GF, Klein G, eds. Advances in cancer research. San Diego, California: Academic Press, 1997:93-119.

13. Papadopoulos, N. & Lindblom, A. Molecular basis of HNPCC: mutations of MMR genes. Hum. Mutat. 1997; 10, 89–99.

14. Thibodeau SN, French AJ, Roche PC, et al. Altered expression of hMSH2 and hMLH1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes. Cancer Res 1996; 56:4836-40.

15. Borresen, A. L., Lothe, R. A., Meling, G. I., et al. Somatic mutations in the hMSH2 gene in microsatellite unstable colorectal carcinomas. Hum. Mol. Genet. 1995; 4, 2065–2072.

16. Bubb VJ, Curtis LJ, Cunningham C, et al. Microsatellite instability and the role of hMSH2 in sporadic colorectal cancer. Oncogene 1996; 12:2641-9.

17. Liu B, Nicolaides NC, Markowitz S, et al. Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability. Nat Genet 1995; 9:48-55.

18. Wu Y, Nystrom-Lahti M, Osinga J, et al. MSH2 and MLH1 mutations in sporadic replication error-positive colorectal carcinoma as assessed by two-dimensional DNA electrophoresis. Genes Chrom Cancer 1997; 18:269-78.

19. Herman, J. G., Merlo, A., Mao, L., et al. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res. 1995; 55, 4525–4530.

20. Merlo, A., Herman, J. G., Mao, L., et al. 5' CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat. Med. 1995; 1, 686–692.

21. Herman, J. G., Latif, F., Weng, Y., et al. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc. Natl. Acad. Sci. USA. 1994; 91, 9700–9704.

22. Jones PA and Laird PW. Cancer epigenetics comes of age. Nat Genet 1999; 21:163-67.

23. Kane MF, Loda M, Gaida GM, et al. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repairdefective human tumor cell lines. Cancer Res 1997;57:808-11.

24. Herman JG, Umar A, Polyak K, et al. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci USA 1998; 95:6870-5.

25. Cunningham JM, Christensen ER, Tester DJ, et al. Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. Cancer Res 1998;58:3455-60.

26. Veigl ML, Kasturi L, Olechnowicz J, et al. Biallelic inactivation of hMLH1 by epigenetic gene silencing, a novel mechanism causing human MSI cancers. Proc Natl Acad Sci USA 1998;95:8698-702.

27. Nakagawa H, Nuovo GJ, Zervos EE, et al. Age related Hypermethylation of the 5’ Region of MLH1 in normal colonic mucosa in associated with microsatellite-unstable colorectal cancer development. Cancer Res 2001; 61:6991-95.

28. Rodriguez-Bigas MA, Boland CR, Hamilton SR, et al. A

National Cancer Institute workshop on hereditary nonpolyposis

colorectal cancer syndrome: meeting highlights and Bethesda Guidelines. J Natl Cancer Inst 1997; 89:1758-62.

29. Simpkins SB, Bocker T, Swisher EM, et al. MLH1 promoter methylation and gene silencing is the primary cause of microsatellite instability in sporadic endometrial cancers. Hum Mol Genet 1999; 8:661-66.

30. Wheeler JMD, Beck NE, Kim HC, et al. Mechanisms of inactivation of mismatch repair genes in colorectal cancer cell lines: The predominant role of hMLH1. Genetics 1999, 96:10296-301.

31. Ramchandani S, MacLeod AR, Pinard M, et al. Inhibition of tumorigenesis by a cytosine-DNA, methyltransferase, antisense oligodeoxynucleotide. Proc Natl Acad Sci USA 1997; 94:684-689.

 

 

 

 

 




Number 27
VOL. 27 (2), 2024
Number 27
VOL. 27 (1), 2024
Number 26
Number 26 VOL. 26(2), 2023 All in one
Number 26
VOL. 26(2), 2023
Number 26
VOL. 26, 2023 Supplement
Number 26
VOL. 26(1), 2023
Number 25
VOL. 25(2), 2022
Number 25
VOL. 25 (1), 2022
Number 24
VOL. 24(2), 2021
Number 24
VOL. 24(1), 2021
Number 23
VOL. 23(2), 2020
Number 22
VOL. 22(2), 2019
Number 22
VOL. 22(1), 2019
Number 22
VOL. 22, 2019 Supplement
Number 21
VOL. 21(2), 2018
Number 21
VOL. 21 (1), 2018
Number 21
VOL. 21, 2018 Supplement
Number 20
VOL. 20 (2), 2017
Number 20
VOL. 20 (1), 2017
Number 19
VOL. 19 (2), 2016
Number 19
VOL. 19 (1), 2016
Number 18
VOL. 18 (2), 2015
Number 18
VOL. 18 (1), 2015
Number 17
VOL. 17 (2), 2014
Number 17
VOL. 17 (1), 2014
Number 16
VOL. 16 (2), 2013
Number 16
VOL. 16 (1), 2013
Number 15
VOL. 15 (2), 2012
Number 15
VOL. 15, 2012 Supplement
Number 15
Vol. 15 (1), 2012
Number 14
14 - Vol. 14 (2), 2011
Number 14
The 9th Balkan Congress of Medical Genetics
Number 14
14 - Vol. 14 (1), 2011
Number 13
Vol. 13 (2), 2010
Number 13
Vol.13 (1), 2010
Number 12
Vol.12 (2), 2009
Number 12
Vol.12 (1), 2009
Number 11
Vol.11 (2),2008
Number 11
Vol.11 (1),2008
Number 10
Vol.10 (2), 2007
Number 10
10 (1),2007
Number 9
1&2, 2006
Number 9
3&4, 2006
Number 8
1&2, 2005
Number 8
3&4, 2004
Number 7
1&2, 2004
Number 6
3&4, 2003
Number 6
1&2, 2003
Number 5
3&4, 2002
Number 5
1&2, 2002
Number 4
Vol.3 (4), 2000
Number 4
Vol.2 (4), 1999
Number 4
Vol.1 (4), 1998
Number 4
3&4, 2001
Number 4
1&2, 2001
Number 3
Vol.3 (3), 2000
Number 3
Vol.2 (3), 1999
Number 3
Vol.1 (3), 1998
Number 2
Vol.3(2), 2000
Number 2
Vol.1 (2), 1998
Number 2
Vol.2 (2), 1999
Number 1
Vol.3 (1), 2000
Number 1
Vol.2 (1), 1999
Number 1
Vol.1 (1), 1998

 

 


 About the journal ::: Editorial ::: Subscription ::: Information for authors ::: Contact
 Copyright © Balkan Journal of Medical Genetics 2006